Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

ALSF 2025 R Accelerated Grant

Alex's Lemonade Stand Foundation (ALSF)

The purpose of the R Accelerated Award Grant is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to scientists focused on pediatric oncology research. Applicants must have an original project that is not currently being funded that has a clear focus on accelerating the discovery of more effective, less toxic therapies for childhood cancers. Research projects should address a testable hypothesis based on strong scientific rationale. Applicants must be a first-time PI or co-PI of a pediatric cancer researchfocused NIH R01 award or equivalent independent award. Demonstration of continued commitment to pediatric cancer investigation as well as institutional support are critical components of a successful application. The R Accelerated Award is a four-year grant.

Specialties

Cancer

Pediatrics

Oncology

Eligibility Requirements

• Applicant institutions must be based in the United States or Canada. Applicants need not be United States citizens. Funds must be granted to nonprofit institutions or organizations.

• Applicants must have an MD, PhD, or MD/PhD, DO, MBBS or equivalent and be within ten years of their first faculty appointment at the Assistant Professor level (higher academic ranks allowed) at the time that their application is submitted.

• Applicants cannot be lead PIs on active ALSF funded grants concurrent with the R Accelerated Award.

• Applicants must be a PI or co-PI of their first independent award such as R01 and must be within five years of the notice of award. A Notice of Award document from the NIH or other funding organization must be submitted with the application. There must be clear documentation of how scientific and budgetary overlap will be avoided.

• R01 equivalent NIH awards include the DP1, DP2, DP5, R37, R56, RF1, RL1, U01 and selected R35 activity codes. Applicants with a K99/R00 award are eligible, if the PI is in the R00 phase of the award at the time of submission. Please read the ALSF R01 equivalency policy for more details.

• Funding from other agencies should be peer-reviewed awards of $200,000 (USD) or more a year for 4 or more years. R01-equivalent grants cannot be mentored-career development awards.

• If applicant's RO1 equivalent award is not listed above or in the ALSF R01 Equivalency policy, prior approval is required, reach out to Margaret Poore at M.Poore@AlexsLemonade.org at least 4 weeks before application due date.

Eligible Countries:

Canada

United States

Sponsor Details

Sponsor Institute/Organizations: Alex's Lemonade Stand Foundation (ALSF)

Sponsor Type: Corporate/Non-Profit

Address: 3 Bala Plaza West Bala Cynwyd, PA 19004

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity